{"CBOE": {"Ticker": "CBOE", "Company": "Cboe Global Markets", "Sector": "Financials", "Updated": "2022-09-30", "Rating": [{"Date": "2022-09-30", "Rating": "Upgrade", "Organization": "Goldman", "Rating_Change": "Sell to Neutral", "Target_Change": "$120 to $126"}, {"Date": "2022-08-17", "Rating": "Initiated", "Organization": "Rosenblatt", "Rating_Change": "Buy", "Target_Change": "$153"}, {"Date": "2022-07-19", "Rating": "Upgrade", "Organization": "Morgan Stanley", "Rating_Change": "Underweight to Overweight", "Target_Change": "$118 to $140"}], "Score": 1.67, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "A", "Analists": ["Rosenblatt", "Goldman", "Morgan Stanley"], "Price_Target": 139.67}, "CNC": {"Ticker": "CNC", "Company": "Centene Corporation", "Sector": "Health Care", "Updated": "2022-09-30", "Rating": [{"Date": "2022-09-30", "Rating": "Initiated", "Organization": "Argus", "Rating_Change": "Buy", "Target_Change": "$90"}, {"Date": "2022-08-26", "Rating": "Downgrade", "Organization": "Wells Fargo", "Rating_Change": "Overweight to Equal Weight", "Target_Change": "$103 to $99"}, {"Date": "2022-07-28", "Rating": "Resumed", "Organization": "Barclays", "Rating_Change": "Overweight", "Target_Change": "$107"}, {"Date": "2022-07-14", "Rating": "Upgrade", "Organization": "Jefferies", "Rating_Change": "Hold to Buy", "Target_Change": "$82 to $115"}], "Score": 0.75, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 4, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Argus", "Jefferies", "Wells Fargo", "Barclays"], "Price_Target": 102.75}, "CRL": {"Ticker": "CRL", "Company": "Charles River Laboratories", "Sector": "Health Care", "Updated": "2022-09-30", "Rating": [{"Date": "2022-09-30", "Rating": "Upgrade", "Organization": "Jefferies", "Rating_Change": "Hold to Buy", "Target_Change": "$240"}, {"Date": "2022-08-25", "Rating": "Initiated", "Organization": "Credit Suisse", "Rating_Change": "Outperform", "Target_Change": "$285"}, {"Date": "2022-08-04", "Rating": "Downgrade", "Organization": "Morgan Stanley", "Rating_Change": "Overweight to Equal-Weight", "Target_Change": "$350 to $250"}], "Score": 0.67, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Credit Suisse", "Jefferies", "Morgan Stanley"], "Price_Target": 258.33}, "GNRC": {"Ticker": "GNRC", "Company": "Generac Holdings", "Sector": "Industrials", "Updated": "2022-09-30", "Rating": [{"Date": "2022-09-30", "Rating": "Initiated", "Organization": "Cowen", "Rating_Change": "Outperform", "Target_Change": "$229"}, {"Date": "2022-09-28", "Rating": "Initiated", "Organization": "Jefferies", "Rating_Change": "Hold", "Target_Change": "$190"}], "Score": 1.0, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Jefferies", "Cowen"], "Price_Target": 209.5}, "JBHT": {"Ticker": "JBHT", "Company": "J. B. Hunt", "Sector": "Industrials", "Updated": "2022-09-30", "Rating": [{"Date": "2022-09-30", "Rating": "Downgrade", "Organization": "KeyBanc Capital Markets", "Rating_Change": "Overweight to Sector Weight", "Target_Change": ""}, {"Date": "2022-07-20", "Rating": "Reiterated", "Organization": "Wolfe Research", "Rating_Change": "Outperform", "Target_Change": "$180 to $185"}, {"Date": "2022-07-20", "Rating": "Reiterated", "Organization": "Wells Fargo", "Rating_Change": "Overweight", "Target_Change": "$183 to $196"}, {"Date": "2022-07-20", "Rating": "Reiterated", "Organization": "UBS", "Rating_Change": "Neutral", "Target_Change": "$186 to $180"}, {"Date": "2022-07-20", "Rating": "Reiterated", "Organization": "Raymond James", "Rating_Change": "Outperform", "Target_Change": "$190 to $200"}, {"Date": "2022-07-20", "Rating": "Reiterated", "Organization": "Evercore ISI", "Rating_Change": "Outperform", "Target_Change": "$207 to $210"}, {"Date": "2022-07-20", "Rating": "Reiterated", "Organization": "Credit Suisse", "Rating_Change": "Neutral", "Target_Change": "$178 to $185"}, {"Date": "2022-07-20", "Rating": "Reiterated", "Organization": "Cowen", "Rating_Change": "Market Perform", "Target_Change": "$188 to $193"}, {"Date": "2022-07-20", "Rating": "Reiterated", "Organization": "BofA Securities", "Rating_Change": "Buy", "Target_Change": "$195 to $203"}], "Score": 0.89, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 9, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Evercore ISI", "Raymond James", "Cowen", "UBS", "BofA Securities", "Credit Suisse", "KeyBanc Capital Markets", "Wolfe Research", "Wells Fargo"], "Price_Target": 194.0}, "MU": {"Ticker": "MU", "Company": "Micron Technology", "Sector": "Information Technology", "Updated": "2022-09-30", "Rating": [{"Date": "2022-09-30", "Rating": "Upgrade", "Organization": "Summit Insights", "Rating_Change": "Hold to Buy", "Target_Change": ""}, {"Date": "2022-09-30", "Rating": "Reiterated", "Organization": "Stifel", "Rating_Change": "Hold", "Target_Change": "$56 to $54"}, {"Date": "2022-09-30", "Rating": "Reiterated", "Organization": "Piper Sandler", "Rating_Change": "Underweight", "Target_Change": "$50 to $45"}, {"Date": "2022-09-30", "Rating": "Reiterated", "Organization": "Needham", "Rating_Change": "Buy", "Target_Change": "$64 to $60"}, {"Date": "2022-09-30", "Rating": "Reiterated", "Organization": "Morgan Stanley", "Rating_Change": "Underweight", "Target_Change": "$56 to $49"}, {"Date": "2022-09-30", "Rating": "Reiterated", "Organization": "Mizuho", "Rating_Change": "Neutral", "Target_Change": "$56 to $52"}, {"Date": "2022-09-30", "Rating": "Reiterated", "Organization": "Deutsche Bank", "Rating_Change": "Buy", "Target_Change": "$68 to $60"}, {"Date": "2022-09-30", "Rating": "Reiterated", "Organization": "BofA Securities", "Rating_Change": "Neutral", "Target_Change": "$62 to $58"}, {"Date": "2022-09-30", "Rating": "Reiterated", "Organization": "BMO Capital Markets", "Rating_Change": "Outperform", "Target_Change": "$80 to $70"}, {"Date": "2022-09-26", "Rating": "Reiterated", "Organization": "Susquehanna", "Rating_Change": "Positive", "Target_Change": "$68 to $60"}, {"Date": "2022-09-21", "Rating": "Initiated", "Organization": "Stifel", "Rating_Change": "Hold", "Target_Change": "$56"}, {"Date": "2022-09-21", "Rating": "Downgrade", "Organization": "Mizuho", "Rating_Change": "Buy to Neutral", "Target_Change": "$75 to $56"}, {"Date": "2022-09-13", "Rating": "Initiated", "Organization": "Exane BNP Paribas", "Rating_Change": "Outperform", "Target_Change": "$75"}, {"Date": "2022-08-09", "Rating": "Downgrade", "Organization": "Raymond James", "Rating_Change": "Strong Buy to Outperform", "Target_Change": "$72 to $65"}, {"Date": "2022-07-22", "Rating": "Downgrade", "Organization": "Morgan Stanley", "Rating_Change": "Equal-Weight to Underweight", "Target_Change": "$56"}], "Score": 0.4, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 15, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Stifel", "Exane BNP Paribas", "Susquehanna", "Summit Insights", "BMO Capital Markets", "Piper Sandler", "Raymond James", "Morgan Stanley", "Needham", "Deutsche Bank", "Mizuho", "BofA Securities"], "Price_Target": 58.29}, "MSFT": {"Ticker": "MSFT", "Company": "Microsoft", "Sector": "Information Technology", "Updated": "2022-09-30", "Rating": [{"Date": "2022-09-30", "Rating": "Resumed", "Organization": "Raymond James", "Rating_Change": "Outperform", "Target_Change": "$300"}, {"Date": "2022-09-22", "Rating": "Initiated", "Organization": "MoffettNathanson", "Rating_Change": "Hold", "Target_Change": "$285"}, {"Date": "2022-08-12", "Rating": "Initiated", "Organization": "Guggenheim", "Rating_Change": "Neutral", "Target_Change": "$292"}, {"Date": "2022-07-27", "Rating": "Reiterated", "Organization": "Wedbush", "Rating_Change": "Outperform", "Target_Change": "$340 to $320"}, {"Date": "2022-07-27", "Rating": "Reiterated", "Organization": "Stifel", "Rating_Change": "Buy", "Target_Change": "$320 to $300"}, {"Date": "2022-07-27", "Rating": "Reiterated", "Organization": "Deutsche Bank", "Rating_Change": "Buy", "Target_Change": "$350 to $330"}, {"Date": "2022-07-27", "Rating": "Reiterated", "Organization": "Cowen", "Rating_Change": "Outperform", "Target_Change": "$330 to $320"}, {"Date": "2022-07-27", "Rating": "Reiterated", "Organization": "Citigroup", "Rating_Change": "Buy", "Target_Change": "$330 to $300"}, {"Date": "2022-07-27", "Rating": "Reiterated", "Organization": "BMO Capital Markets", "Rating_Change": "Outperform", "Target_Change": "$305 to $320"}, {"Date": "2022-07-26", "Rating": "Initiated", "Organization": "Itau BBA", "Rating_Change": "Outperform", "Target_Change": "$287"}, {"Date": "2022-07-19", "Rating": "Reiterated", "Organization": "Citigroup", "Rating_Change": "Buy", "Target_Change": "$364 to $330"}], "Score": 1.64, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 11, "Period": "180 days", "Letter_Rating": "A", "Analists": ["Stifel", "Citigroup", "Cowen", "Raymond James", "BMO Capital Markets", "Wedbush", "Itau BBA", "Deutsche Bank", "Guggenheim", "MoffettNathanson"], "Price_Target": 307.64}, "NKE": {"Ticker": "NKE", "Company": "Nike", "Sector": "Consumer Discretionary", "Updated": "2022-09-30", "Rating": [{"Date": "2022-09-30", "Rating": "Reiterated", "Organization": "UBS", "Rating_Change": "Buy", "Target_Change": "$156 to $141"}, {"Date": "2022-09-30", "Rating": "Reiterated", "Organization": "Telsey Advisory Group", "Rating_Change": "Outperform", "Target_Change": "$125 to $110"}, {"Date": "2022-09-30", "Rating": "Reiterated", "Organization": "Stifel", "Rating_Change": "Buy", "Target_Change": "$130 to $110"}, {"Date": "2022-09-30", "Rating": "Reiterated", "Organization": "RBC Capital Mkts", "Rating_Change": "Outperform", "Target_Change": "$125 to $115"}, {"Date": "2022-09-30", "Rating": "Reiterated", "Organization": "Piper Sandler", "Rating_Change": "Neutral", "Target_Change": "$115 to $95"}, {"Date": "2022-09-30", "Rating": "Reiterated", "Organization": "Morgan Stanley", "Rating_Change": "Overweight", "Target_Change": "$129 to $120"}, {"Date": "2022-09-30", "Rating": "Reiterated", "Organization": "JP Morgan", "Rating_Change": "Overweight", "Target_Change": "$130 to $120"}, {"Date": "2022-09-30", "Rating": "Reiterated", "Organization": "Jefferies", "Rating_Change": "Buy", "Target_Change": "$130 to $115"}, {"Date": "2022-09-30", "Rating": "Reiterated", "Organization": "Guggenheim", "Rating_Change": "Buy", "Target_Change": "$155 to $135"}, {"Date": "2022-09-30", "Rating": "Reiterated", "Organization": "Deutsche Bank", "Rating_Change": "Buy", "Target_Change": "$123 to $99"}, {"Date": "2022-09-30", "Rating": "Reiterated", "Organization": "Credit Suisse", "Rating_Change": "Outperform", "Target_Change": "$124 to $110"}, {"Date": "2022-09-30", "Rating": "Reiterated", "Organization": "Cowen", "Rating_Change": "Outperform", "Target_Change": "$127 to $114"}, {"Date": "2022-09-30", "Rating": "Reiterated", "Organization": "Citigroup", "Rating_Change": "Neutral", "Target_Change": "$113 to $93"}, {"Date": "2022-09-30", "Rating": "Reiterated", "Organization": "BofA Securities", "Rating_Change": "Neutral", "Target_Change": "$122 to $100"}, {"Date": "2022-09-26", "Rating": "Reiterated", "Organization": "Telsey Advisory Group", "Rating_Change": "Outperform", "Target_Change": "$130 to $125"}, {"Date": "2022-09-22", "Rating": "Initiated", "Organization": "RBC Capital Mkts", "Rating_Change": "Outperform", "Target_Change": "$125"}, {"Date": "2022-09-20", "Rating": "Downgrade", "Organization": "Barclays", "Rating_Change": "Overweight to Equal Weight", "Target_Change": "$125 to $110"}, {"Date": "2022-08-09", "Rating": "Downgrade", "Organization": "Exane BNP Paribas", "Rating_Change": "Outperform to Neutral", "Target_Change": "$118"}, {"Date": "2022-07-26", "Rating": "Resumed", "Organization": "Piper Sandler", "Rating_Change": "Neutral", "Target_Change": "$115"}, {"Date": "2022-07-21", "Rating": "Initiated", "Organization": "KeyBanc Capital Markets", "Rating_Change": "Sector Weight", "Target_Change": ""}], "Score": 1.1, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 20, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Stifel", "Exane BNP Paribas", "Citigroup", "Cowen", "Piper Sandler", "RBC Capital Mkts", "Jefferies", "Morgan Stanley", "Barclays", "UBS", "JP Morgan", "Deutsche Bank", "Credit Suisse", "Guggenheim", "KeyBanc Capital Markets", "BofA Securities", "Telsey Advisory Group"], "Price_Target": 114.21}}